Thu-Ha Dinh1, Mary L Kamb, Veerle Msimang, Muptal Likibi, Thabo Molebatsi, Thurma Goldman, David A Lewis. 1. From the *Centers for Disease Control and Prevention, Division of Global HIV/AIDS (CDC/DGHA), Atlanta, GA; †Centers for Disease Control and Prevention, Division of Sexually Transmitted Disease Prevention (CDC/DSTDP), Atlanta, GA; ‡National Institute for Communicable Diseases of the National Health Laboratory Service (NICD/NHLS), Johannesburg, South Africa; §Gauteng Department of Health, Johannesburg, South Africa; ¶Northern Cape Department of Health, Kimberly, South Africa; and∥Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Abstract
BACKGROUND: South Africa recommends universal syphilis and HIV testing in pregnancy, with prompt antiretroviral therapy or penicillin treatment for women testing positive. METHODS: We used a multistage, purposeful sampling strategy to retrospectively identify clinical records from a sample (7.3%) of 32,518 women delivering from January 2005 to June 2006 at 6 public clinics in the Northern Cape and Gauteng. Descriptive analyses and logistic regression were used to assess coverage and factors related to testing and treatment of HIV and syphilis. RESULTS: Of 2379 women sampled, 93% accessed antenatal care (ANC) services during pregnancy and 71% before the third pregnancy trimester. Testing during pregnancy or delivery was 74% for HIV and 84% for syphilis; testing at the first ANC visit was 41% and 71%; and infection prevalence at delivery was 14% and 5%, respectively. Of 243 women with reactive HIV tests, 104 (43%) had treatment documented (single-dose nevirapine) before delivery. Of 98 women with reactive syphilis tests, 73% had documented receipt of 1 penicillin injection and 36% had all 3 recommended injections. Multivariable analysis found women tested for syphilis were almost 4 times more likely to have had no HIV test compared with those without syphilis testing (adjusted odds ratios, 3.9; 95% confidence interval, 1.7-5.5). CONCLUSIONS: Integration and provision of a package of HIV and syphilis testing at the first ANC visit and decentralizing treatments of both infections to primary care settings could increase the coverage of testing and treatment services, thus enhancing the effectiveness of current programs eliminating mother-to-child transmission of HIV and syphilis.
BACKGROUND: South Africa recommends universal syphilis and HIV testing in pregnancy, with prompt antiretroviral therapy or penicillin treatment for women testing positive. METHODS: We used a multistage, purposeful sampling strategy to retrospectively identify clinical records from a sample (7.3%) of 32,518 women delivering from January 2005 to June 2006 at 6 public clinics in the Northern Cape and Gauteng. Descriptive analyses and logistic regression were used to assess coverage and factors related to testing and treatment of HIV and syphilis. RESULTS: Of 2379 women sampled, 93% accessed antenatal care (ANC) services during pregnancy and 71% before the third pregnancy trimester. Testing during pregnancy or delivery was 74% for HIV and 84% for syphilis; testing at the first ANC visit was 41% and 71%; and infection prevalence at delivery was 14% and 5%, respectively. Of 243 women with reactive HIV tests, 104 (43%) had treatment documented (single-dose nevirapine) before delivery. Of 98 women with reactive syphilis tests, 73% had documented receipt of 1 penicillin injection and 36% had all 3 recommended injections. Multivariable analysis found women tested for syphilis were almost 4 times more likely to have had no HIV test compared with those without syphilis testing (adjusted odds ratios, 3.9; 95% confidence interval, 1.7-5.5). CONCLUSIONS: Integration and provision of a package of HIV and syphilis testing at the first ANC visit and decentralizing treatments of both infections to primary care settings could increase the coverage of testing and treatment services, thus enhancing the effectiveness of current programs eliminating mother-to-child transmission of HIV and syphilis.
Authors: Jami S Leichliter; David A Lewis; Maya Sternberg; Melissa A Habel; Gabriela Paz-Bailey Journal: Sex Transm Dis Date: 2011-09 Impact factor: 2.830
Authors: Deborah Watson-Jones; John Changalucha; Balthazar Gumodoka; Helen Weiss; Mary Rusizoka; Leonard Ndeki; Anne Whitehouse; Rebecca Balira; James Todd; Donatila Ngeleja; David Ross; Anne Buvé; Richard Hayes; David Mabey Journal: J Infect Dis Date: 2002-09-03 Impact factor: 5.226
Authors: Gabriela B Gomez; Mary L Kamb; Lori M Newman; Jennifer Mark; Nathalie Broutet; Sarah J Hawkes Journal: Bull World Health Organ Date: 2013-01-17 Impact factor: 9.408
Authors: F Terris-Prestholt; D Watson-Jones; K Mugeye; L Kumaranayake; L Ndeki; H Weiss; J Changalucha; J Todd; F Lisekie; B Gumodoka; D Mabey; R Hayes Journal: Sex Transm Infect Date: 2003-10 Impact factor: 3.519
Authors: Claire C Bristow; Segundo R Leon; Emily Huang; Lourdes B Ramos; Silver K Vargas; Juan A Flores; Kelika A Konda; Carlos F Caceres; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2016-01 Impact factor: 2.830
Authors: Brandy L Peterson Maddox; Shauntā S Wright; Hazel Namadingo; Virginia B Bowen; Geoffrey A Chipungu; Mary L Kamb Journal: Sex Transm Infect Date: 2017-12 Impact factor: 3.519
Authors: Claire C Bristow; Sung-Jae Lee; Linda Severe; Jean William Pape; Marjan Javanbakht; Warren Scott Comulada; Jeffrey D Klausner Journal: Int J STD AIDS Date: 2016-07-10 Impact factor: 1.359
Authors: Andreas Kuznik; Christine Muhumuza; Henry Komakech; Elsa M R Marques; Mohammed Lamorde Journal: PLoS One Date: 2015-05-26 Impact factor: 3.240
Authors: Claire C Bristow; Yaw Adu-Sarkodie; Raphael O Ondondo; Elizabeth Anne Bukusi; Claver Anoumou Dagnra; Khin Yi Oo; Eh Htoo Pe; Chanthavysouk Khamsay; Le Thi Houng; Roberto Vázquez Campuzano; Jason Estes; Jeffrey D Klausner Journal: Open Forum Infect Dis Date: 2014-05-27 Impact factor: 3.835